COMBINATION THERAPY

• 收藏
• 分享

专利权人:

NUCANA BIOMED LIMITED

发明人:

Hugh Griffith

申请号：

US16065476

公开号：

US20190381084A1

申请日:

2015.12.23

申请国别(地区):

US

年份:

2019

代理人:

摘要：

This invention relates to a combination of gemcitabine-[phenyl-(benzoxy-L-alaninyl)]-phosphate (chemical name: 2′；-Deoxy-2′；,2′；-difluoro-D-cytidine-5′；-O-[phenyl (benzoxy-L-alaninyl)] phosphate) (NUC-1031) and a platinum-based anticancer agent selected from cisplatin, picoplatin, lipoplatin and triplatin. The combinations are useful in the treatment of cancer, particularly biliary tract and bladder cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/